127 related articles for article (PubMed ID: 1569143)
1. Endothelium-derived relaxing factor inhibits constrictor responses of large cerebral arteries to serotonin.
Faraci FM; Heistad DD
J Cereb Blood Flow Metab; 1992 May; 12(3):500-6. PubMed ID: 1569143
[TBL] [Abstract][Full Text] [Related]
2. Role of the L-arginine-nitric oxide pathway in the changes in cerebrovascular reactivity following hemorrhagic hypotension and retransfusion.
Szabó C; Csáki C; Benyó Z; Reivich M; Kovách AG
Circ Shock; 1992 Aug; 37(4):307-16. PubMed ID: 1446389
[TBL] [Abstract][Full Text] [Related]
3. Detailed examination of vascular lesions triggered by an inhibitor of endothelium-derived relaxing factor.
Tagami M; Ikeda K; Nara Y; Fujino H; Kubota A; Numano F; Yamori Y
Lab Invest; 1995 Feb; 72(2):174-82. PubMed ID: 7853851
[TBL] [Abstract][Full Text] [Related]
4. Endothelium-derived relaxing factor is important in mediating the high output state in chronic severe anemia.
Anand IS; Chandrashekhar Y; Wander GS; Chawla LS
J Am Coll Cardiol; 1995 May; 25(6):1402-7. PubMed ID: 7722140
[TBL] [Abstract][Full Text] [Related]
5. NG-nitro-L-arginine antagonizes endothelium-dependent dilator responses by inhibiting endothelium-derived relaxing factor release in the isolated rabbit heart.
Lamontagne D; Pohl U; Busse R
Pflugers Arch; 1991 Apr; 418(3):266-70. PubMed ID: 1649992
[TBL] [Abstract][Full Text] [Related]
6. [Hemodynamic effects of sub-chronic NO synthase inhibition in conscious dogs: role of EDRF/NO in muscular exertion].
Puybasset L; Béa ML; Simon L; Ghaleh B; Giudicelli JF; Berdeaux A
Arch Mal Coeur Vaiss; 1995 Aug; 88(8):1217-21. PubMed ID: 8572877
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release.
Vargas HM; Cuevas JM; Ignarro LJ; Chaudhuri G
J Pharmacol Exp Ther; 1991 Jun; 257(3):1208-15. PubMed ID: 1646327
[TBL] [Abstract][Full Text] [Related]
8. Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide.
Koedel U; Bernatowicz A; Paul R; Frei K; Fontana A; Pfister HW
Ann Neurol; 1995 Mar; 37(3):313-23. PubMed ID: 7535035
[TBL] [Abstract][Full Text] [Related]
9. L-NAME enhances pulmonary vasoconstriction without inhibiting EDRF-dependent vasodilation.
Lippton HL; Hao Q; Hyman A
J Appl Physiol (1985); 1992 Dec; 73(6):2432-9. PubMed ID: 1490955
[TBL] [Abstract][Full Text] [Related]
10. Modulation of cerebral arterial tone by endothelium-derived relaxing factor.
Brian JE; Kennedy RH
Am J Physiol; 1993 Apr; 264(4 Pt 2):H1245-50. PubMed ID: 8476102
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of nitric oxide synthase induces a selective reduction in tumor blood flow that is reversible with L-arginine.
Tozer GM; Prise VE; Chaplin DJ
Cancer Res; 1997 Mar; 57(5):948-55. PubMed ID: 9041200
[TBL] [Abstract][Full Text] [Related]
12. Evidence of a role for compounds derived from arginine in coronary response to serotonin in vivo.
Cappelli-Bigazzi M; Nuno DW; Lamping KG
Am J Physiol; 1991 Aug; 261(2 Pt 2):H404-9. PubMed ID: 1877667
[TBL] [Abstract][Full Text] [Related]
13. N-nitro L-arginine causes coronary vasoconstriction and inhibits endothelium-dependent vasodilatation in anaesthetized greyhounds.
Woodman OL; Dusting GJ
Br J Pharmacol; 1991 Jun; 103(2):1407-10. PubMed ID: 1909199
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary vasoconstriction during lidocaine administration are modulated by endothelium-derived relaxing factor.
Hayashi M
Osaka City Med J; 1998 Dec; 44(2):181-94. PubMed ID: 10097598
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of noradrenergic constriction of large coronary arteries by inhibition of nitric oxide synthesis in anaesthetized dogs.
Woodman OL; Pannangpetch P
Br J Pharmacol; 1994 Jun; 112(2):443-8. PubMed ID: 7915608
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-derived relaxing factor modulates noradrenergic constriction of cerebral arterioles in rabbits.
Bauknight GC; Faraci FM; Heistad DD
Stroke; 1992 Oct; 23(10):1522-5; discussion 1525-6. PubMed ID: 1412591
[TBL] [Abstract][Full Text] [Related]
17. EDRF suppresses an unidentified vasoconstrictor mechanism in hypertensive rat lungs.
Oka M; Hasunuma K; Webb SA; Stelzner TJ; Rodman DM; McMurtry IF
Am J Physiol; 1993 Jun; 264(6 Pt 1):L587-97. PubMed ID: 8333550
[TBL] [Abstract][Full Text] [Related]
18. NG-nitro-L-arginine and phenylephrine have similar effects on the vascular waterfall in the canine hindlimb.
Shrier I; Magder S
J Appl Physiol (1985); 1995 Feb; 78(2):478-82. PubMed ID: 7759415
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (nitric oxide) formation/release in anesthetized dogs.
Klabunde RE; Ritger RC; Helgren MC
Eur J Pharmacol; 1991 Jun; 199(1):51-9. PubMed ID: 1893927
[TBL] [Abstract][Full Text] [Related]
20. Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation.
Faraci FM
Am J Physiol; 1991 Oct; 261(4 Pt 2):H1038-42. PubMed ID: 1928387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
